Logo image of CNXC

CONCENTRIX CORP (CNXC) Stock Fundamental Analysis

NASDAQ:CNXC - Nasdaq - US20602D1019 - Common Stock - Currency: USD

45.5  +0.06 (+0.13%)

Fundamental Rating

5

Taking everything into account, CNXC scores 5 out of 10 in our fundamental rating. CNXC was compared to 82 industry peers in the IT Services industry. While CNXC is still in line with the averages on profitability rating, there are concerns on its financial health. CNXC scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CNXC had positive earnings in the past year.
In the past year CNXC had a positive cash flow from operations.
Each year in the past 5 years CNXC has been profitable.
In the past 5 years CNXC always reported a positive cash flow from operatings.
CNXC Yearly Net Income VS EBIT VS OCF VS FCFCNXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

CNXC's Return On Assets of 2.43% is in line compared to the rest of the industry. CNXC outperforms 56.41% of its industry peers.
The Return On Equity of CNXC (7.22%) is better than 61.54% of its industry peers.
The Return On Invested Capital of CNXC (7.50%) is better than 67.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNXC is below the industry average of 10.27%.
The last Return On Invested Capital (7.50%) for CNXC is above the 3 year average (7.17%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.43%
ROE 7.22%
ROIC 7.5%
ROA(3y)3.63%
ROA(5y)4.4%
ROE(3y)9.77%
ROE(5y)10.34%
ROIC(3y)7.17%
ROIC(5y)7.81%
CNXC Yearly ROA, ROE, ROICCNXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 2.43%, CNXC is in line with its industry, outperforming 56.41% of the companies in the same industry.
In the last couple of years the Profit Margin of CNXC has remained more or less at the same level.
Looking at the Operating Margin, with a value of 7.75%, CNXC is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
In the last couple of years the Operating Margin of CNXC has remained more or less at the same level.
CNXC's Gross Margin of 35.81% is in line compared to the rest of the industry. CNXC outperforms 56.41% of its industry peers.
CNXC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.75%
PM (TTM) 2.43%
GM 35.81%
OM growth 3Y-7.9%
OM growth 5Y0.21%
PM growth 3Y-29.45%
PM growth 5Y0.19%
GM growth 3Y0.57%
GM growth 5Y-0.7%
CNXC Yearly Profit, Operating, Gross MarginsCNXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNXC is destroying value.
Compared to 1 year ago, CNXC has less shares outstanding
CNXC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CNXC has remained at the same level compared to a year ago.
CNXC Yearly Shares OutstandingCNXC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CNXC Yearly Total Debt VS Total AssetsCNXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

CNXC has an Altman-Z score of 1.70. This is a bad value and indicates that CNXC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CNXC (1.70) is worse than 64.10% of its industry peers.
CNXC has a debt to FCF ratio of 11.05. This is a negative value and a sign of low solvency as CNXC would need 11.05 years to pay back of all of its debts.
CNXC's Debt to FCF ratio of 11.05 is on the low side compared to the rest of the industry. CNXC is outperformed by 62.82% of its industry peers.
CNXC has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
CNXC's Debt to Equity ratio of 1.17 is on the low side compared to the rest of the industry. CNXC is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 11.05
Altman-Z 1.7
ROIC/WACC0.84
WACC8.91%
CNXC Yearly LT Debt VS Equity VS FCFCNXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.42 indicates that CNXC should not have too much problems paying its short term obligations.
CNXC has a Current ratio of 1.42. This is comparable to the rest of the industry: CNXC outperforms 43.59% of its industry peers.
A Quick Ratio of 1.42 indicates that CNXC should not have too much problems paying its short term obligations.
CNXC has a Quick ratio (1.42) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
CNXC Yearly Current Assets VS Current LiabilitesCNXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.62% over the past year.
Measured over the past years, CNXC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.35% on average per year.
Looking at the last year, CNXC shows a very strong growth in Revenue. The Revenue has grown by 68.97%.
The Revenue has been growing by 15.36% on average over the past years. This is quite good.
EPS 1Y (TTM)0.62%
EPS 3Y3.95%
EPS 5Y10.35%
EPS Q2Q%-2.98%
Revenue 1Y (TTM)68.97%
Revenue growth 3Y19.85%
Revenue growth 5Y15.36%
Sales Q2Q%9.74%

3.2 Future

The Earnings Per Share is expected to grow by 5.56% on average over the next years.
Based on estimates for the next years, CNXC will show a small growth in Revenue. The Revenue will grow by 2.32% on average per year.
EPS Next Y2%
EPS Next 2Y5.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.65%
Revenue Next 2Y0.69%
Revenue Next 3Y2.32%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CNXC Yearly Revenue VS EstimatesCNXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
CNXC Yearly EPS VS EstimatesCNXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

CNXC is valuated cheaply with a Price/Earnings ratio of 3.99.
Compared to the rest of the industry, the Price/Earnings ratio of CNXC indicates a rather cheap valuation: CNXC is cheaper than 98.72% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.36. CNXC is valued rather cheaply when compared to this.
CNXC is valuated cheaply with a Price/Forward Earnings ratio of 3.92.
Based on the Price/Forward Earnings ratio, CNXC is valued cheaply inside the industry as 98.72% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, CNXC is valued rather cheaply.
Industry RankSector Rank
PE 3.99
Fwd PE 3.92
CNXC Price Earnings VS Forward Price EarningsCNXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNXC is valued cheaper than 94.87% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNXC indicates a rather cheap valuation: CNXC is cheaper than 94.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.83
EV/EBITDA 4.53
CNXC Per share dataCNXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNXC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CNXC may justify a higher PE ratio.
PEG (NY)2
PEG (5Y)0.39
EPS Next 2Y5.56%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CNXC has a Yearly Dividend Yield of 2.77%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.94, CNXC pays a better dividend. On top of this CNXC pays more dividend than 96.15% of the companies listed in the same industry.
CNXC's Dividend Yield is a higher than the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.77%

5.2 History

CNXC has been paying a dividend for over 5 years, so it has already some track record.
CNXC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
CNXC Yearly Dividends per shareCNXC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

28.72% of the earnings are spent on dividend by CNXC. This is a low number and sustainable payout ratio.
DP28.72%
EPS Next 2Y5.56%
EPS Next 3YN/A
CNXC Yearly Income VS Free CF VS DividendCNXC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CNXC Dividend Payout.CNXC Dividend Payout, showing the Payout Ratio.CNXC Dividend Payout.PayoutRetained Earnings

CONCENTRIX CORP

NASDAQ:CNXC (2/27/2025, 3:25:09 PM)

45.5

+0.06 (+0.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)01-15 2025-01-15/amc
Earnings (Next)03-24 2025-03-24/amc
Inst Owners90.78%
Inst Owner Change5.47%
Ins Owners2.95%
Ins Owner Change0.77%
Market Cap2.93B
Analysts81.67
Price Target68.17 (49.82%)
Short Float %14.51%
Short Ratio10.84
Dividend
Industry RankSector Rank
Dividend Yield 2.77%
Yearly Dividend1.29
Dividend Growth(5Y)N/A
DP28.72%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-31 2025-01-31 (0.33275)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.18%
Min EPS beat(2)-3.89%
Max EPS beat(2)6.25%
EPS beat(4)2
Avg EPS beat(4)0.12%
Min EPS beat(4)-3.89%
Max EPS beat(4)6.25%
EPS beat(8)3
Avg EPS beat(8)-0.82%
EPS beat(12)5
Avg EPS beat(12)-1.31%
EPS beat(16)9
Avg EPS beat(16)0.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.7%
Min Revenue beat(2)-1.75%
Max Revenue beat(2)-1.65%
Revenue beat(4)0
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-1.75%
Max Revenue beat(4)-0.6%
Revenue beat(8)0
Avg Revenue beat(8)-1.76%
Revenue beat(12)0
Avg Revenue beat(12)-2.1%
Revenue beat(16)1
Avg Revenue beat(16)-1.67%
PT rev (1m)-9.07%
PT rev (3m)-13.02%
EPS NQ rev (1m)-13.36%
EPS NQ rev (3m)-15.15%
EPS NY rev (1m)-5.42%
EPS NY rev (3m)-7.44%
Revenue NQ rev (1m)-4.06%
Revenue NQ rev (3m)-4.06%
Revenue NY rev (1m)-1.04%
Revenue NY rev (3m)-2.83%
Valuation
Industry RankSector Rank
PE 3.99
Fwd PE 3.92
P/S 0.24
P/FCF 6.83
P/OCF 4.39
P/B 0.73
P/tB N/A
EV/EBITDA 4.53
EPS(TTM)11.39
EY25.03%
EPS(NY)11.62
Fwd EY25.53%
FCF(TTM)6.66
FCFY14.63%
OCF(TTM)10.36
OCFY22.78%
SpS186.67
BVpS62.73
TBVpS-50.22
PEG (NY)2
PEG (5Y)0.39
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 7.22%
ROCE 9.32%
ROIC 7.5%
ROICexc 7.68%
ROICexgc 30.2%
OM 7.75%
PM (TTM) 2.43%
GM 35.81%
FCFM 3.57%
ROA(3y)3.63%
ROA(5y)4.4%
ROE(3y)9.77%
ROE(5y)10.34%
ROIC(3y)7.17%
ROIC(5y)7.81%
ROICexc(3y)7.36%
ROICexc(5y)8.08%
ROICexgc(3y)28.93%
ROICexgc(5y)27.59%
ROCE(3y)8.91%
ROCE(5y)9.71%
ROICexcg growth 3Y-8.2%
ROICexcg growth 5Y-1.87%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-3.98%
OM growth 3Y-7.9%
OM growth 5Y0.21%
PM growth 3Y-29.45%
PM growth 5Y0.19%
GM growth 3Y0.57%
GM growth 5Y-0.7%
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 11.05
Debt/EBITDA 2.89
Cap/Depr 33.83%
Cap/Sales 1.99%
Interest Coverage 3.3
Cash Conversion 40.76%
Profit Quality 146.92%
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 1.7
F-Score7
WACC8.91%
ROIC/WACC0.84
Cap/Depr(3y)41.85%
Cap/Depr(5y)48.26%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.71%
Profit Quality(3y)148.84%
Profit Quality(5y)148.38%
High Growth Momentum
Growth
EPS 1Y (TTM)0.62%
EPS 3Y3.95%
EPS 5Y10.35%
EPS Q2Q%-2.98%
EPS Next Y2%
EPS Next 2Y5.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)68.97%
Revenue growth 3Y19.85%
Revenue growth 5Y15.36%
Sales Q2Q%9.74%
Revenue Next Year-0.65%
Revenue Next 2Y0.69%
Revenue Next 3Y2.32%
Revenue Next 5YN/A
EBIT growth 1Y27.18%
EBIT growth 3Y10.38%
EBIT growth 5Y15.6%
EBIT Next Year30.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.82%
FCF growth 3Y5.5%
FCF growth 5Y4.83%
OCF growth 1Y-1.55%
OCF growth 3Y9.09%
OCF growth 5Y8.22%